Effect of Psorakot Plus Cream along with Internal Medicines in Psoriasis Skin Lesions

Add on effect of Psorakot plus cream along with internal medications in skin lesions associated with Psoriasis- A Comparative Clinical Trial - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/10/096058

Enrollment

Registered

2025-10-14

Start date

Unknown

Completion date

Unknown

Last updated

2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80-L99- Other disorders of the skin and subcutaneous tissue

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Participants with skin lesions (rounded erythematous, dry scaling patches) satisfying the diagnostic criteria of psoriasis 2.

Exclusion criteria

Exclusion criteria: 1.Lactating and pregnant women 2.Diagnosed cases of any malignancies, hepatic/ renal dysfunction, CAD 3.Participants with psoriatic complications - Arthritis, Secondary infection, Tumour formation

Design outcomes

Primary

Measure	Time frame
Assessments will be done using PASI (Psoriasis Area Severity Index)- BT and ATTimepoint: 14days	—

Secondary

Measure	Time frame
NILTimepoint:	—

Countries

India

Contacts

Public ContactDr Anoop AK

Vaidyaratnam P S Variers Aryavaidyasala Kottakkal

dranoopak86@gmail.com04832806520

Outcome results